PODD
Insulet Corporation
Past performance does not guarantee future results. The data presented is indicative and may not be updated in real-time.
Insulet Corporation makes a special device called the Omnipod, which helps people with diabetes manage their insulin levels. This device is small, sticky, and can be worn on the body for three days without needing to be replaced. It is wireless and comes with a handheld manager that helps users control their insulin delivery. The company sells these products in several countries, including the United States and Canada, to help make life easier for those who need insulin.
Streams of revenue
Geographic Distribution
Core Products
Business Type
Business to Consumer
Competitive Advantages
Key Business Risks
Meeting Expectations
Higher values indicate better execution and credibility
Recent Results
2024-11-07
2024-08-08
Takeaways
Insulet Corporation has a strong position in the insulin delivery market with its innovative Omnipod System, benefiting from a growing diabetes population and favorable industry dynamics. However, potential risks from competition and regulatory challenges warrant caution.
Historical data shows an impressive CAGR compared with the USA stock market average, reflecting a strong market position.
10Y annualized return is
excellent
at 24.4% per year
PODD has met or exceeded earnings expectations in
some
recent quarters (1/2)
Continue with...